Seria Co., Ltd. (TYO:2782)

Inozyme Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	233,242	188,550	226,471	197,278	208,640	293,120
Market Cap Growth	-7.99%	-16.74%	14.80%	-5.45%	-28.82%	23.68%
Enterprise Value	172,133	127,288	166,111	134,411	145,621	236,652
Last Close Price	3100.00	2506.00	2939.43	2491.73	2564.80	3500.41
PE Ratio	20.56	16.81	23.06	19.24	14.59	19.91
PS Ratio	0.98	0.80	1.01	0.93	1.00	1.46
PB Ratio	2.16	1.75	2.22	2.02	2.26	3.44
P/TBV Ratio	2.17	1.75	2.22	2.03	2.26	3.44
P/FCF Ratio	-	17.25	31.99	29.29	15.56	19.82
P/OCF Ratio	-	11.78	18.51	17.40	11.82	15.07
EV/Sales Ratio	0.72	0.54	0.74	0.63	0.70	1.18
EV/EBITDA Ratio	7.79	5.82	8.31	6.71	5.79	9.38
EV/EBIT Ratio	10.12	7.56	10.99	8.70	6.96	11.13
EV/FCF Ratio	-	11.65	23.47	19.96	10.86	16.00
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.02	0.02
Debt / EBITDA Ratio	0.06	0.07	0.09	0.09	0.08	0.08
Debt / FCF Ratio	-	0.13	0.25	0.28	0.15	0.14
Asset Turnover	1.77	1.72	1.72	1.70	1.75	1.85
Inventory Turnover	5.93	6.01	6.10	6.24	6.33	6.57
Quick Ratio	3.14	2.91	2.94	2.99	2.78	2.55
Current Ratio	4.31	3.91	3.96	3.98	3.64	3.37
Return on Equity (ROE)	10.79%	10.68%	9.85%	10.80%	16.10%	18.38%
Return on Assets (ROA)	7.88%	7.67%	7.28%	7.74%	10.98%	12.26%
Return on Capital (ROIC)	9.97%	9.87%	9.30%	9.96%	14.39%	16.17%
Return on Capital Employed (ROCE)	14.60%	14.50%	13.80%	14.70%	21.10%	23.20%
Earnings Yield	4.86%	5.95%	4.34%	5.20%	6.85%	5.02%
FCF Yield	-	5.80%	3.13%	3.41%	6.43%	5.05%
Payout Ratio	-	46.94%	53.61%	51.36%	37.12%	30.90%
Buyback Yield / Dilution	-	0.00%	0.00%	0.71%	0.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.